IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0283977.html
   My bibliography  Save this article

A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers

Author

Listed:
  • Michael Krautmann
  • Ben Davis
  • Pascale R Leroueil

Abstract

Although vaccination is widely considered one of the most cost-effective health interventions available, global coverage rates for many vaccines remain lower than necessary for disease elimination and eradication. New vaccine technologies can play an important role in addressing barriers to vaccination and increasing coverage rates. To identify and prioritize vaccine technology investments, decision makers must be able to compare the overall costs and benefits of each investment option. While these data points may exist, they are often confined to silos. Decision makers would benefit from a model that synthesizes this broad range of data and provides clear and actionable information. To facilitate vaccine investment, purchasing and deployment decisions, we developed a systematic and transparent cost-benefit model that estimates the value and risk of a given investment scenario from the perspective of both “buyers” (e.g., global donors, country governments) and “sellers” (e.g., developers, manufacturers) of vaccines. This model, which can be used to evaluate scenarios related to a single vaccine presentation or a portfolio of vaccine presentations, leverages our published approach for estimating the impact of improved vaccine technologies on vaccination coverage rates. This article presents a description of the model and provides an illustrative example application to a portfolio of measles-rubella vaccine technologies currently under development. Although the model is generally applicable to organizations involved in vaccine investment, manufacturing or purchasing, we believe it may be particularly useful to those engaged in vaccine markets that rely strongly on funding from institutional donors.

Suggested Citation

  • Michael Krautmann & Ben Davis & Pascale R Leroueil, 2023. "A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers," PLOS ONE, Public Library of Science, vol. 18(4), pages 1-22, April.
    • Handle: RePEc:plo:pone00:0283977
    DOI: 10.1371/journal.pone.0283977
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0283977
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0283977&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0283977?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Viscusi, W. Kip & Masterman, Clayton J., 2017. "Income Elasticities and Global Values of a Statistical Life," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 8(2), pages 226-250, July.
    2. Robinson, Lisa A. & Hammitt, James K. & O’Keeffe, Lucy, 2019. "Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 10(S1), pages 15-50, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. St-Amour, Pascal, 2024. "Valuing life over the life cycle," Journal of Health Economics, Elsevier, vol. 93(C).
    2. Marcela V. Parada‐Contzen, 2019. "The Value of a Statistical Life for Risk‐Averse and Risk‐Seeking Individuals," Risk Analysis, John Wiley & Sons, vol. 39(11), pages 2369-2390, November.
    3. Claxton, Karl & Asaria, Miqdad & Chansa, Collins & Jamison, Julian & Lomas, James & Ochalek, Jessica & Paulden, Mike, 2019. "Accounting for timing when assessing health-related policies," LSE Research Online Documents on Economics 100038, London School of Economics and Political Science, LSE Library.
    4. Jianhua Xu & Shiwei Fan & Jiakun Zheng, 2025. "Valuing mortality risk reductions in the time of COVID-19: A stated-preference analysis," Post-Print hal-04909840, HAL.
    5. Lavin, Felipe Vasquez & Bratti, Luna & Orrego, Sergio & Barrientos, Manuel, 2020. "Assessing the Use of Pseudo-panels to Estimate the Value of Statistical Life in Developing Countries," EfD Discussion Paper 20-20, Environment for Development, University of Gothenburg.
    6. Shaun Da Costa, 2021. "Estimating the welfare gains from antiretroviral therapy in Sub-Saharan Africa," Working Papers 2101, Herman Deleeck Centre for Social Policy, University of Antwerp.
    7. James K. Hammitt & Fangli Geng & Xiaoqi Guo & Chris P. Nielsen, 2019. "Valuing mortality risk in China: Comparing stated-preference estimates from 2005 and 2016," Journal of Risk and Uncertainty, Springer, vol. 58(2), pages 167-186, June.
    8. Jose Valderrama & Javier Olivera, 2023. "The effects of social pensions on mortality among the extreme poor elderly," LISER Working Paper Series 2023-05, Luxembourg Institute of Socio-Economic Research (LISER).
    9. Anthony Boardman & Jeff Geng & Bruno Lam, 2020. "The Social Cost of Informal Electronic Waste Processing in Southern China," Administrative Sciences, MDPI, vol. 10(1), pages 1-20, February.
    10. Da Costa, Shaun, 2023. "Estimating the welfare gains from anti-retroviral therapy in Sub-Saharan Africa," Journal of Health Economics, Elsevier, vol. 90(C).
    11. Shaun M. Da Costa, 2020. "The impact of the Ebola crisis on mortality and welfare in Liberia," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1517-1532, December.
    12. Newbold, Stephen C. & Dockins, Chris & Simon, Nathalie & Maguire, Kelly & Sakib, Abdullah, 2024. "A two-stage random-effects meta-analysis of value per statistical life estimates," National Center for Environmental Economics-NCEE Working Papers 348912, United States Environmental Protection Agency (EPA).
    13. Daniel Johnson & Judith Exl & Sylvie Geisendorf, 2021. "The Potential of Stormwater Management in Addressing the Urban Heat Island Effect: An Economic Valuation," Sustainability, MDPI, vol. 13(16), pages 1-19, August.
    14. Jaithri Ananthapavan & Marj Moodie & Andrew J. Milat & Rob Carter, 2021. "Systematic Review to Update ‘Value of a Statistical Life’ Estimates for Australia," IJERPH, MDPI, vol. 18(11), pages 1-17, June.
    15. Claxton, Karl & Asaria, Miqdad & Chansa, Collins & Jamison, Julian & Lomas, James & Ochalek, Jessica & Paulden, Mike, 2019. "Accounting for Timing when Assessing Health-Related Policies," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 10(S1), pages 73-105, April.
    16. Shaun Da Costa, 2023. "Estimating the value of life expectancy gains in Tanzania using the life satisfaction and model based approaches," Health Economics, John Wiley & Sons, Ltd., vol. 32(5), pages 1040-1063, May.
    17. Ivan C. Hanigan & Richard A. Broome & Timothy B. Chaston & Martin Cope & Martine Dennekamp & Jane S. Heyworth & Katharine Heathcote & Joshua A. Horsley & Bin Jalaludin & Edward Jegasothy & Fay H. John, 2020. "Avoidable Mortality Attributable to Anthropogenic Fine Particulate Matter (PM 2.5 ) in Australia," IJERPH, MDPI, vol. 18(1), pages 1-9, December.
    18. James K. Hammitt, 2020. "Valuing mortality risk in the time of COVID-19," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 129-154, October.
    19. Boniface Oyugi & Olena Nizalova & Sally Kendall & Stephen Peckham, 2024. "Does a free maternity policy in Kenya work? Impact and cost–benefit consideration based on demographic health survey data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(1), pages 77-89, February.
    20. Donfouet,Hermann Pythagore Pierre & Sanogo,Ndoh Ashken & Gogoua,Amantchi Jean - Noel & Tshivuila Matala,Opope Oyaka & Traore,Adama-000558561 & Sorgho,Gaston, 2024. "Mortality Costs of and Policy Responses to the COVID-19 Pandemic in Côte d'Ivoire," Policy Research Working Paper Series 10731, The World Bank.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0283977. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.